Auf dieser Seite
VRDN Viridian Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$19,40
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$13,1852-Wochen-Tief
$34,2952-Wochen-Hoch
Marktkapitalisierung (MRQ)
$2.20B
P/E
-4.8
EPS
$-5.31
Umsatz
$71M
Ihre Abzeichen
52W-Spanne
$13–$34
Analystenbewertung
BUY
Kursziel
$37
P/E
-4.8
ROE
-55.4%
Nettogewinnmarge
-544.1%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
VRDN Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$19.40
Marktkapitalisierung (MRQ)
$2.20B
P/E
-4.8
EPS
$-5.31
Umsatz
$71M
ROE
-55.4%
52W-Spanne
$13–$34
VRDN Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 13. November 2020 | 1-for-15 | Umgekehrt |
| 7. November 2016 | 1-for-15 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$71M2016-12-31 → 2025-12-31
EPS$-5.312020-12-31 → 2023-12-31
Freier Cashflow$-277M2016-12-31 → 2025-12-31
Nettogewinnmarge-544.1%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | VRDN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -4.85-Jahres-Durchschnitt ≈-5.3 | ≈-5.3 | · | · | |
| P/S (TTM) | 30.95-Jahres-Durchschnitt ≈1954.2 | ≈1954.2 | 25.9 | Fairer Wert | |
| K/B (MRQ) | 3.35-Jahres-Durchschnitt ≈3.0 | ≈3.0 | 4.6 | Unterbewertet | |
| Kurs / FCF (TTM) | -6.65-Jahres-Durchschnitt ≈-9.2 | ≈-9.2 | · | · | |
| Kurs / Cashflow (TTM) | -6.65-Jahres-Durchschnitt ≈-9.2 | ≈-9.2 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 3.45-Jahres-Durchschnitt ≈3.0 | ≈3.0 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | VRDN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -569.7%5-Jahres-Durchschnitt ≈-38167.2% | ≈-38167.2% | -668.2% | Schwach | |
| EBITDA-Marge (TTM) | -569.0%5-Jahres-Durchschnitt ≈-38094.4% | ≈-38094.4% | -668.2% | Schwach | |
| Nettogewinnmarge (TTM) | -544.1%5-Jahres-Durchschnitt ≈-35118.3% | ≈-35118.3% | -669.0% | Schwach | |
| ROA | -41.7%5-Jahres-Durchschnitt ≈-45.0% | ≈-45.0% | -38.7% | Im Einklang | |
| ROE | -55.4%5-Jahres-Durchschnitt ≈-46.6% | ≈-46.6% | -59.1% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | VRDN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 16.95-Jahres-Durchschnitt ≈14.8 | ≈14.8 | 8.5 | Starke Liquidität | |
| Quick Ratio | 12.45-Jahres-Durchschnitt ≈16.8 | ≈16.8 | 4.5 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | VRDN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 23359.9%5-Jahres-Durchschnitt ≈4683.2% | ≈4683.2% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 242.0%5-Jahres-Durchschnitt ≈51.8% | ≈51.8% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 132.2% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | VRDN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.15-Jahres-Durchschnitt ≈0.0 | ≈0.0 | 0.1 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$281.1K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
17.4%
Nächster Bericht
Nov 03, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-1.05 | $-1.05 | -0.01% |
| 31. März 2026 | Mai 12, 2026 | $-0.90 | $-1.12 | 19.4% |
| 31. Dezember 2025 | $-1.08 | $-1.09 | 0.96% | |
| 30. September 2025 | $-0.34 | $-1.10 | 69.2% | |
| 30. Juni 2025 | $-1.00 | $-1.03 | 2.9% | |
| 31. März 2025 | $-0.87 | $-0.99 | 11.8% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71M | $302.0K | $314.0K | $2M | $3M | $1M | $4M | $8M | $4M | $3M | $3M | $6M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | $3M | $2M | $3M | |
| R&D Expense | · | · | · | · | · | · | $35M | $30M | $20M | $14M | $1M | $347.0K | |
| SG&A Expense | $95M | $61M | $95M | $35M | $26M | $13M | $12M | $11M | $11M | $7M | $8M | $7M | |
| Operating Expenses | $434M | $299M | $255M | $136M | $83M | $111M | $46M | $41M | $31M | $20M | $14M | $11M | |
| Operating Income | $-363M | $-299M | $-254M | $-134M | $-80M | $-110M | $-42M | $-33M | $-27M | $-17M | $-11M | $-7M | |
| Interest Expense | · | · | · | $500.0K | · | · | · | · | · | $95.0K | $141.0K | $1M | |
| Interest Income | $27M | $32M | $18M | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $21M | $29M | $17M | $4M | $315.0K | $173.0K | $941.0K | · | · | · | · | · | |
| Income Tax | $0 | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Income | $-343M | $-270M | $-238M | $-130M | $-79M | $-111M | $-42M | $-33M | $-27M | $-17M | $-11M | $-8M | |
| EPS (Basic) | · | · | $-5.31 | $-4.05 | $-6.66 | $-31.13 | · | · | · | · | · | · | |
| EPS (Diluted) | · | · | $-5.31 | $-4.05 | $-6.66 | $-31.13 | · | · | · | · | · | · | |
| Shares (Basic) | · | · | 44,755,475 | 32,087,293 | 11,918,712 | 3,557,065 | · | · | · | · | · | · | |
| Shares (Diluted) | · | · | 44,755,475 | 32,087,293 | 11,918,712 | 3,557,065 | · | · | · | · | · | · | |
| EBITDA | $-363M | $-298M | $-254M | $-134M | $-80M | $-110M | $-42M | $-33M | · | $-12M | · | $-7M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $875M | $718M | $477M | $425M | $197M | $128M | $27M | $33M | $47M | $22M | $21M | $5M | |
| Short-term Investments | · | · | · | · | $155M | $82M | $2M | $30M | $0 | · | · | · | |
| Receivables | · | · | · | · | · | · | $108.0K | $24.0K | $1M | $20.0K | $394.0K | $1M | |
| Inventory | · | · | · | · | · | · | · | · | · | $64.0K | $187.0K | $179.0K | |
| Prepaid Expense | $20M | $21M | $9M | $7M | $3M | $2M | $3M | $3M | $3M | $2M | $321.0K | $399.0K | |
| Current Assets | $894M | $738M | $486M | $431M | $200M | $130M | $30M | $65M | $52M | $24M | $12M | $7M | |
| PP&E (Net) | $1M | $1M | $2M | $1M | $375.0K | $309.0K | $523.0K | $727.0K | $563.0K | $625.0K | $1M | $1M | |
| PP&E (Gross) | $2M | $3M | $3M | $3M | $2M | $4M | $4M | $4M | $3M | $3M | $2M | $2M | |
| Accum. Depreciation | $1M | $1M | $1M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $739.0K | $555.0K | |
| Intangibles | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $2M | $501.0K | $604.0K | $982.0K | $1M | $1.0K | $0 | $50.0K | $50.0K | $258.0K | · | · | |
| Total Assets | $899M | $742M | $490M | $435M | $204M | $131M | $30M | $66M | $52M | $25M | $13M | $8M | |
| Accounts Payable | $9M | $2M | $2M | $14M | $2M | $670.0K | $1M | $571.0K | $906.0K | $1M | $242.0K | $255.0K | |
| Accrued Liabilities | $62M | $46M | $24M | $19M | $11M | $10M | $5M | $4M | $3M | $4M | $1M | $361.0K | |
| Short-term Debt | · | · | · | · | · | $0 | $4M | $2M | $0 | $2M | · | · | |
| Current Liabilities | $71M | $48M | $27M | $33M | $14M | $11M | $10M | $7M | $4M | $7M | $2M | $2M | |
| Capital Leases | $2M | $2M | $1M | $1M | $1M | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $2M | $989.0K | $1M | $1M | $43.0K | $0 | $66.0K | $152.0K | $0 | $24.0K | $109.0K | |
| Total Liabilities | $177M | $71M | $48M | $40M | $16M | $11M | $15M | $15M | $14M | $10M | · | · | |
| Long-term Debt | · | $21M | $20M | $5M | $0 | · | $8M | $10M | $10M | · | · | · | |
| Total Debt | · | $21M | · | · | · | $0 | $4M | $2M | · | · | · | · | |
| Common Stock | $1M | $810.0K | $540.0K | $414.0K | $239.0K | $42.0K | $23.0K | $308.0K | $226.0K | $8.0K | $7.0K | $38.0K | |
| Paid-in Capital | $1.93B | $1.48B | $961M | $741M | $412M | $218M | $184M | $177M | $132M | $5M | $28M | $13M | |
| Retained Earnings | $-1.34B | $-996M | $-726M | $-488M | $-358M | $-279M | $-168M | $-126M | $-94M | $-67M | $-18M | $-7M | |
| AOCI | $447.0K | $-10.0K | $338.0K | $-390.0K | $-157.0K | $-8.0K | $0 | $-3.0K | $0 | · | · | · | |
| Stockholders' Equity | $722M | $672M | $442M | $395M | $188M | $120M | $16M | $51M | $39M | $-62M | $-45M | $6M | |
| Liabilities + Equity | $899M | $742M | $490M | $435M | $204M | $131M | $30M | $66M | $52M | $25M | $13M | $8M | |
| Shares Outstanding | 101,826,500 | 80,994,046 | 53,986,112 | 41,305,947 | 23,924,004 | 4,231,135 | 2,324,126 | 30,839,463 | 22,568,006 | 833,744 | 601,667 | 3,782,629 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $460.0K | $540.0K | $522.0K | $255.0K | $120.0K | $239.0K | $288.0K | $281.0K | $308.0K | $341.0K | $184.0K | $144.0K | |
| Stock-based Comp | $44M | $42M | $67M | $20M | $14M | $4M | $4M | $4M | $2M | $198.0K | $3M | $4M | |
| Restructuring | · | · | · | · | · | $300.0K | $2M | · | · | · | · | · | |
| Other Non-cash | $21M | $-5M | $-14M | $16M | $10M | $77M | $2M | $2M | · | $3M | · | $1M | |
| Operating Cash Flow | $-276M | $-232M | $-184M | $-94M | $-55M | $-30M | $-36M | $-27M | $-28M | $-15M | $-7M | $-2M | |
| CapEx | $495.0K | $511.0K | $898.0K | $797.0K | $338.0K | $42.0K | $84.0K | $445.0K | $246.0K | $250.0K | $123.0K | $266.0K | |
| Investing Cash Flow | $-38M | $-229M | $-94M | $-115M | $-74M | $-50M | $28M | $-30M | $1M | $-250.0K | $-95.0K | $-274.0K | |
| Debt Issued | $29M | $0 | $15M | $5M | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $29M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $63M | $70M | $15M | $292M | $114M | $0 | $2M | $45M | · | · | $13M | $7M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | $2.0K | · | · | |
| Net Stock Activity | $63M | $454M | $125M | $292M | $114M | · | $2M | · | · | $-2.0K | · | $7M | |
| Financing Cash Flow | $427M | $458M | $226M | $322M | $125M | $101M | $70.0K | $42M | $52M | $16M | $13M | $7M | |
| Net Change in Cash | $113M | $-3M | $-53M | $113M | $-4M | $21M | $-8M | $-15M | $25M | · | · | · | |
| Free Cash Flow | $-277M | $-233M | $-185M | $-95M | $-55M | $-30M | $-36M | $-27M | · | $-7M | · | $-2M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -512.9% | -99018.2% | -81035.0% | -7579.2% | -2690.8% | -10512.4% | -941.0% | -394.5% | · | -374.8% | · | -105.9% | |
| Net Margin | -483.6% | -89387.1% | -75711.5% | -7329.2% | -2680.2% | -10544.3% | -938.6% | -390.0% | · | -379.8% | · | -121.7% | |
| EBITDA Margin | -512.3% | -98839.4% | -80868.8% | -7564.8% | -2686.7% | -10489.6% | -934.6% | -391.2% | · | -369.2% | · | -103.7% | |
| ROA | -41.7% | -43.8% | -51.4% | -40.7% | -47.4% | -137.1% | -86.9% | -55.1% | · | -147.7% | · | -134.2% | |
| ROE | -55.4% | -39.1% | -65.5% | -32.3% | -40.5% | -156.9% | -215.2% | -58.4% | · | 55.6% | · | 88.2% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.6 | 15.4 | 18.3 | 12.9 | 14.7 | 12.1 | 2.9 | 9.7 | · | 0.9 | · | 3.4 | |
| Quick Ratio | 12.4 | 15.0 | 17.9 | 12.7 | 25.8 | 19.6 | 2.8 | 9.3 | · | 0.8 | · | 3.1 | |
| Debt / Equity | · | 0.0 | · | · | · | 0.0 | 0.3 | 0.0 | · | · | · | · | |
| LT Debt / Equity | · | 0.0 | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | -268.6 | · | · | · | · | · | -131.7 | · | -6.7 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | · | 0.4 | · | 1.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | 20.3 | · | 12.1 | |
| Receivables Turnover | · | · | · | · | · | · | 67.6 | 11.3 | · | 7.3 | · | 6.2 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.09 | $8.29 | $8.19 | $9.56 | $7.85 | $28.37 | $0.45 | $1.66 | · | $-0.44 | · | $1.58 | |
| Revenue / Share | · | · | $0.01 | $0.06 | $0.25 | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | · | $-4.12 | $-2.92 | $-4.58 | · | · | · | · | · | · | · | |
| Cash / Share | $8.59 | $8.86 | $8.84 | $10.28 | $8.23 | $30.16 | $0.77 | $1.06 | · | $4.50 | · | $1.35 | |
| EPS (TTM) | $-4.05 | $-4.05 | $-5.31 | $-4.05 | $-6.66 | $-31.13 | · | · | · | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 23359.9% | -3.8% | -82.3% | -40.2% | 182.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 242.0% | -53.3% | -33.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 132.2% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $71M | $302.0K | $314.0K | $2M | $3M | $1M | $4M | $8M | $4M | $3M | $3M | $6M | |
| Net Income TTM | $-343M | $-270M | $-238M | $-130M | $-79M | $-111M | $-42M | $-33M | $-27M | $-17M | $-11M | $-8M | |
| Market Cap | $3.17B | $1.55B | $1.18B | $1.21B | $473M | $70M | $251M | $1.40B | · | $56M | · | $2.16B | |
| Enterprise Value | · | $856M | · | · | · | $-140M | $226M | $1.34B | · | · | · | · | |
| P/E | -7.7 | -4.7 | -4.1 | -7.2 | -3.0 | -0.5 | · | · | · | · | · | · | |
| P/S | 44.7 | 5141.2 | 3744.6 | 680.9 | 159.6 | 66.3 | 56.3 | 167.1 | · | 16.0 | · | 333.4 | |
| P/B | 4.4 | 2.3 | 2.7 | 3.1 | 2.5 | 0.6 | 15.9 | 27.3 | · | -171.1 | · | 360.8 | |
| P / Tangible Book | 4.4 | 2.3 | 2.7 | 3.1 | 2.5 | 0.6 | · | · | · | · | · | · | |
| P / Cash Flow | -11.5 | -6.7 | -6.4 | -12.9 | -8.7 | -2.3 | -7.0 | -52.2 | · | -7.7 | · | -976.9 | |
| P / FCF | -11.4 | -6.7 | -6.4 | -12.7 | -8.6 | -2.3 | -6.9 | -51.4 | · | -7.7 | · | -872.0 | |
| EV / EBITDA | · | -2.9 | · | · | · | 1.3 | -5.4 | -40.9 | · | · | · | · | |
| EV / FCF | · | -3.7 | · | · | · | 4.7 | -6.3 | -49.2 | · | · | · | · | |
| EV / Revenue | · | 2833.2 | · | · | · | -133.1 | 50.7 | 160.0 | · | · | · | · | |
| Earnings Yield | -13.0% | -21.1% | -24.4% | -13.9% | -33.7% | -189.2% | · | · | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $284.0K | $141.0K | $132.0K | $71M | $75.0K | $72.0K | $72.0K | $86.0K | $72.0K | $72.0K | $72.0K | $72.0K | $98.0K | $1M | $256.0K | $216.0K | |
| SG&A Expense | $55M | $39M | $34M | $24M | $20M | $17M | $16M | $14M | $16M | $15M | $21M | $19M | $22M | $9M | $8M | $8M | |
| Operating Expenses | $127M | $116M | $123M | $111M | $107M | $94M | $88M | $84M | $72M | $56M | $51M | $59M | $73M | $31M | $30M | $26M | |
| Operating Income | $-126M | $-116M | $-123M | $-40M | $-107M | $-94M | $-87M | $-83M | $-72M | $-56M | $-51M | $-59M | $-72M | $-30M | $-30M | $-26M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $200.0K | $200.0K | $200.0K | $200.0K | $0 | |
| Interest Income | $8M | $8M | $8M | $6M | $7M | $8M | $9M | $8M | · | · | · | · | · | · | · | · | |
| Other Non-op | $-851.0K | $11M | $2M | $5M | $6M | $7M | $8M | $7M | $7M | $7M | $4M | $4M | $4M | $880.0K | $73.0K | $196.0K | |
| Net Income | $-127M | $-105M | $-120M | $-35M | $-101M | $-87M | $-80M | $-77M | $-65M | $-49M | $-48M | $-55M | $-68M | $-29M | $-29M | $-26M | |
| EPS (Basic) | · | · | · | · | · | · | · | $-1.15 | $-1.02 | $-0.79 | $-1.09 | $-1.27 | $-1.61 | $-0.86 | $-1.06 | $-0.98 | |
| EPS (Diluted) | · | · | · | · | · | · | · | $-1.15 | $-1.02 | $-0.79 | $-1.09 | $-1.27 | $-1.61 | $-0.86 | $-1.06 | $-0.98 | |
| Shares (Basic) | · | · | · | · | · | · | · | 66,420,063 | 63,854,514 | 61,099,038 | 43,654,577 | 43,253,457 | 42,242,309 | 33,742,076 | 27,762,257 | 26,126,092 | |
| Shares (Diluted) | · | · | · | · | 81,593,463 | 81,344,134 | · | 66,420,063 | 63,854,514 | 61,099,038 | 43,654,577 | 43,253,457 | 42,242,309 | 33,742,076 | 27,762,257 | 26,126,092 | |
| EBITDA | · | $-116M | · | $-40M | $-107M | $-94M | · | $-83M | $-72M | $-56M | $-51M | $-59M | $-72M | $-30M | $-30M | $-26M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $982M | $762M | $875M | $491M | $563M | $637M | · | $753M | $571M | $613M | $313M | $334M | $374M | $431M | $161M | $175M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $145M | |
| Prepaid Expense | $25M | $23M | $20M | $11M | $15M | $21M | $21M | $14M | $10M | $14M | $11M | $12M | $9M | $6M | $4M | $3M | |
| Current Assets | $1.08B | $785M | $894M | $572M | $579M | $657M | $738M | $767M | $582M | $627M | $324M | $346M | $383M | $437M | $166M | $179M | |
| PP&E (Net) | $3M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $825.0K | $749.0K | $691.0K | |
| PP&E (Gross) | · | · | $2M | · | · | · | $3M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $1M | · | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $1M | $888.0K | $2M | $2M | $506.0K | $489.0K | $501.0K | $853.0K | $659.0K | $555.0K | $1M | $1M | $982.0K | $1M | $2M | $2M | |
| Total Assets | $1.10B | $789M | $899M | $577M | $582M | $661M | $742M | $772M | $586M | $630M | $329M | $351M | $387M | $441M | $170M | $183M | |
| Accounts Payable | $9M | $13M | $9M | $10M | $9M | $4M | $2M | $6M | $3M | $3M | $4M | $4M | $8M | $12M | $4M | $3M | |
| Accrued Liabilities | $55M | $38M | $62M | $41M | $35M | $30M | $46M | $35M | $30M | $23M | $19M | $24M | $21M | $13M | $17M | $12M | |
| Current Liabilities | $64M | $52M | $71M | $51M | $53M | $34M | $48M | $41M | $37M | $26M | $23M | $29M | $30M | $25M | $21M | $14M | |
| Capital Leases | · | · | $2M | $2M | $2M | $2M | · | $2M | $2M | $900.0K | $1M | $1M | $1M | $800.0K | $900.0K | $1M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $896.0K | $1M | $2M | $1M | $813.0K | $938.0K | $1M | |
| Total Liabilities | $435M | $153M | $177M | $74M | $67M | $57M | $71M | $64M | $56M | $48M | $45M | $36M | $36M | $32M | $28M | $17M | |
| Long-term Debt | · | · | · | · | $21M | · | · | · | $20M | $20M | $20M | $5M | $5M | $5M | $5M | · | |
| Total Debt | · | · | · | $21M | $21M | $21M | · | $21M | $20M | · | · | · | · | · | · | · | |
| Common Stock | $1M | $1M | $1M | $822.0K | $817.0K | $816.0K | $810.0K | $792.0K | $639.0K | $638.0K | $437.0K | $436.0K | $431.0K | $402.0K | $285.0K | $272.0K | |
| Paid-in Capital | $2.13B | $1.95B | $1.93B | $1.53B | $1.51B | $1.50B | $1.48B | $1.43B | $1.17B | $1.16B | $807M | $792M | $772M | $710M | $453M | $439M | |
| Retained Earnings | $-1.57B | $-1.44B | $-1.34B | $-1.22B | $-1.18B | $-1.08B | $-996M | $-916M | $-839M | $-774M | $-659M | $-611M | $-556M | $-442M | $-413M | $-384M | |
| AOCI | $-1M | $-558.0K | $447.0K | $363.0K | $69.0K | $245.0K | $-10.0K | $932.0K | $-543.0K | $-367.0K | $-64.0K | $-173.0K | $-174.0K | $-940.0K | $-1M | $-935.0K | |
| Stockholders' Equity | $662M | $636M | $722M | $503M | $515M | $604M | $672M | $707M | $529M | $583M | $284M | $316M | $351M | $409M | $142M | $167M | |
| Liabilities + Equity | $1.10B | $789M | $899M | $577M | $582M | $661M | $742M | $772M | $586M | $630M | $329M | $351M | $387M | $441M | $170M | $183M | |
| Shares Outstanding | 113,238,218 | 102,458,094 | 101,826,500 | 82,229,158 | 81,651,186 | 81,589,427 | 80,994,046 | 79,181,445 | 63,879,675 | 63,798,536 | 43,700,989 | 43,562,208 | 43,055,318 | 40,244,355 | 28,463,980 | 23,924,004 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $117.0K | $121.0K | $120.0K | $110.0K | $113.0K | $117.0K | $123.0K | $130.0K | $142.0K | $145.0K | $135.0K | $132.0K | $105.0K | $62.0K | $57.0K | $40.0K | |
| Stock-based Comp | $17M | $13M | $12M | $11M | $11M | $10M | $9M | $9M | $12M | $13M | $14M | $12M | $15M | $5M | $5M | $5M | |
| Other Non-cash | · | $-28M | · | · | · | $-16M | · | · | · | $-10M | · | · | $-9M | · | · | $-48.0K | |
| Operating Cash Flow | $-105M | $-120M | $-24M | $-85M | $-75M | $-93M | $-73M | $-68M | $-46M | $-45M | $-39M | $-45M | $-62M | $-21M | $-18M | $-21M | |
| CapEx | $1M | $23.0K | $240.0K | $127.0K | $42.0K | $86.0K | $114.0K | $293.0K | $104.0K | $0 | $404.0K | $331.0K | $115.0K | $95.0K | $292.0K | $179.0K | |
| Investing Cash Flow | $-231M | $77M | $-339M | $126M | $76M | $100M | $-63M | $-85M | $62M | $-143M | $48M | $41M | $-13M | $43M | $14M | $9M | |
| Debt Issued | · | · | · | · | · | · | $0 | · | · | · | $15M | · | · | $0 | · | · | |
| Stock Issued | $0 | $0 | $48M | $10M | $1.0K | $5M | $34M | $-150M | $0 | $186M | $0 | $0 | $0 | $267M | · | · | |
| Net Stock Activity | · | $0 | · | · | · | · | · | · | · | $186M | · | · | · | · | · | · | |
| Financing Cash Flow | $325M | $6M | $406M | $11M | $764.0K | $9M | $36M | $245M | $108.0K | $177M | $15M | $3M | $8M | $291M | $5M | $738.0K | |
| Net Change in Cash | $-11M | $-36M | $43M | $52M | $1M | $17M | $-101M | $93M | $16M | $-11M | $25M | $-1M | $-67M | $313M | $435.0K | $-11M | |
| Free Cash Flow | · | $-120M | · | · | · | $-93M | · | · | · | $-45M | · | · | $-62M | · | · | $-21M |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -82389.4% | · | -56.7% | -142356.0% | -130369.4% | · | -97069.8% | -100259.7% | -77634.7% | -71144.4% | -82326.4% | -73952.0% | -2492.5% | -11548.4% | -11985.6% | |
| Net Margin | · | -74397.9% | · | -49.0% | -134313.3% | -120711.1% | · | -89173.3% | -90268.1% | -67419.4% | -66194.4% | -76476.4% | -69541.8% | -2418.8% | -11519.9% | -11894.9% | |
| EBITDA Margin | · | -82303.5% | · | -56.7% | -142356.0% | -130206.9% | · | -97069.8% | -100259.7% | -77433.3% | -71144.4% | -82326.4% | -73844.9% | -2492.5% | -11548.4% | -11967.1% | |
| ROA | · | -14.5% | · | -5.1% | -17.2% | -13.5% | · | -13.9% | -13.9% | -9.6% | -12.4% | -21.1% | -23.9% | -8.7% | -20.5% | -16.8% | |
| ROE | · | -16.9% | · | -5.7% | -19.3% | -14.6% | · | -15.5% | -15.4% | -10.4% | -13.8% | -24.1% | -26.4% | -9.4% | -24.5% | -18.9% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 15.1 | · | 11.3 | 11.0 | 19.5 | · | 18.6 | 15.8 | 24.0 | 13.9 | 12.1 | 12.9 | 17.3 | 7.8 | 12.5 | |
| Quick Ratio | · | 14.7 | · | 9.7 | 10.7 | 18.9 | · | 18.2 | 15.5 | 23.5 | 13.5 | 11.7 | 12.6 | 17.1 | 7.5 | 22.2 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -296.4 | -362.4 | -148.9 | -147.8 | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $6.21 | · | $6.12 | $6.31 | $7.41 | · | $8.94 | $8.29 | $9.13 | $6.49 | $7.25 | $8.14 | $10.16 | $4.99 | $6.97 | |
| Revenue / Share | · | · | · | · | · | · | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 | $0.01 | $0.01 | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | $-0.74 | · | · | $-1.47 | · | · | $-0.81 | |
| Cash / Share | · | $7.44 | · | $5.97 | $6.90 | $7.80 | · | $9.51 | $8.94 | $9.61 | $7.16 | $7.67 | $8.68 | $10.72 | $5.66 | $7.33 | |
| EPS (TTM) | $-4.05 | · | · | · | · | · | · | · | · | · | · | · | · | $-3.19 | $-3.58 | $-4.73 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $71M | $71M | · | $71M | $305.0K | $302.0K | · | $302.0K | $288.0K | $288.0K | $347.0K | $1M | $2M | $2M | $894.0K | $2M | |
| Net Income TTM | $-367M | $-361M | · | $-302M | $-344M | $-308M | · | $-257M | $-228M | $-218M | $-217M | $-198M | $-172M | $-113M | $-98M | $-87M | |
| Market Cap | · | $2.00B | · | $1.77B | $1.14B | $1.10B | · | $1.80B | $831M | $1.12B | $670M | $1.04B | $1.10B | $825M | $329M | $442M | |
| Enterprise Value | · | · | · | $1.30B | $599M | $484M | · | $1.07B | $280M | · | · | · | · | · | · | · | |
| P/E | -4.5 | · | · | · | · | · | · | · | · | · | · | · | · | -6.4 | -3.2 | -3.9 | |
| P/S | · | 28.3 | · | 25.1 | 3742.6 | 3641.8 | · | 5964.8 | 2885.7 | 3878.9 | 1931.9 | 705.0 | 662.2 | 438.8 | 368.4 | 256.0 | |
| P/B | 3.1 | 3.2 | · | 3.5 | 2.2 | 1.8 | · | 2.5 | 1.6 | 1.9 | 2.4 | 3.3 | 3.1 | 2.0 | 2.3 | 2.7 | |
| P / Tangible Book | 3.2 | 3.2 | · | 3.5 | 2.2 | 1.8 | · | 2.5 | 1.6 | 1.9 | 2.4 | 3.3 | 3.1 | 2.0 | 2.3 | 2.7 | |
| P / Cash Flow | · | -16.7 | · | · | · | -11.9 | · | · | · | -24.7 | · | · | -17.7 | · | · | -21.0 | |
| EV / Revenue | · | · | · | 18.4 | 1963.5 | 1602.4 | · | 3538.7 | 972.7 | · | · | · | · | · | · | · | |
| Earnings Yield | -22.1% | · | · | · | · | · | · | · | · | · | · | · | · | -15.6% | -30.9% | -25.6% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $71M | $302.0K | $314.0K | $2M | $3M |
| Betriebsgewinnmarge % | -512.9% | -99018.2% | -81035.0% | -7579.2% | -2690.8% |
| Nettoergebnis | $-343M | $-270M | $-238M | $-130M | $-79M |
| Verwässerte EPS | · | · | $-5.31 | $-4.05 | $-6.66 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | · | 0.0 | · | · | · |
| Liquiditätsgrad | 12.6 | 15.4 | 18.3 | 12.9 | 14.7 |
| Quick Ratio | 12.4 | 15.0 | 17.9 | 12.7 | 25.8 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-277M | $-233M | $-185M | $-95M | $-55M |
Institutionelle Eigentümer (13F) 226 Einreicher · $2.6B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
226
Gehaltener Wert
$2.6B
Neue Positionen
51
Geschlossene Positionen
51
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 51 (-4 vs. Vorquartal) | 51 (+4 vs. Vorquartal) | 93 (+12 vs. Vorquartal) | 52 (-11 vs. Vorquartal) | +22.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $305.029.074 | 16.604.740 | 11,87% | Aktien |
| VANGUARD GROUP INC | $174.649.921 | 5.612.144 | 6,79% | Aktien |
| BlackRock, Inc. | $157.090.835 | 8.551.488 | 6,11% | Aktien |
| Bellevue Group AG | $123.665.169 | 6.731.909 | 4,81% | Aktien |
| Paradigm Biocapital Advisors LP | $123.515.986 | 6.723.788 | 4,81% | Aktien |
| Kynam Capital Management, LP | $118.557.720 | 6.453.877 | 4,61% | Aktien |
| STATE STREET CORP | $112.515.809 | 6.124.976 | 4,38% | Aktien |
| Fairmount Funds Management LLC | $93.520.347 | 5.090.928 | 3,64% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $84.076.918 | 4.576.860 | 3,27% | Aktien |
| Deep Track Capital, LP | $65.998.634 | 3.592.740 | 2,57% | Aktien |
| Venrock Adviser, LLC | $59.847.935 | 3.257.917 | 2,33% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $57.468.009 | 3.128.362 | 2,24% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $50.569.432 | 2.752.827 | 1,97% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $45.968.039 | 2.501.869 | 1,79% | Aktien |
| Avoro Capital Advisors LLC | $45.925.000 | 2.500.000 | 1,79% | Aktien |
| BAKER BROS. ADVISORS LP | $43.776.169 | 2.383.025 | 1,70% | Aktien |
| Point72 Asset Management, L.P. | $43.044.731 | 2.343.208 | 1,67% | Aktien |
| Caligan Partners LP | $40.303.431 | 2.193.981 | 1,57% | Aktien |
| NOVO HOLDINGS A/S | $39.219.950 | 2.135.000 | 1,53% | Aktien |
| TANG CAPITAL MANAGEMENT LLC | $32.930.540 | 1.792.626 | 1,28% | Aktien |
| Fisher Asset Management, LLC | $32.163.113 | 1.750.850 | 1,25% | Aktien |
| Candriam S.C.A. | $31.340.230 | 1.707.698 | 1,22% | Aktien |
| GOLDMAN SACHS GROUP INC | $31.069.254 | 1.691.304 | 1,21% | Aktien |
| First Turn Management, LLC | $30.677.900 | 1.670.000 | 1,19% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $29.607.274 | 1.611.521 | 1,15% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $27.220.459 | 1.391.639 | 1,06% | Aktien |
| UBS Group AG | $26.247.845 | 1.428.843 | 1,02% | Aktien |
| Parkman Healthcare Partners LLC | $25.306.071 | 1.377.576 | 0,98% | Aktien |
| Balyasny Asset Management L.P. | $23.511.010 | 1.279.859 | 0,91% | Aktien |
| D. E. Shaw & Co., Inc. | $21.717.418 | 1.182.222 | 0,84% | Aktien |
| RICE HALL JAMES & ASSOCIATES, LLC | $21.601.393 | 1.175.906 | 0,84% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $20.435.027 | 1.112.413 | 0,79% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $18.592.975 | 1.012.138 | 0,72% | Aktien |
| Elmind Capital, LP | $18.093.182 | 984.931 | 0,70% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $17.375.111 | 888.298 | 0,68% | Aktien |
| BANK OF AMERICA CORP /DE/ | $17.347.618 | 944.345 | 0,67% | Aktien |
| NORTHERN TRUST CORP | $15.862.330 | 863.491 | 0,62% | Aktien |
| Eversept Partners, LP | $15.268.079 | 831.142 | 0,59% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $14.972.046 | 815.027 | 0,58% | Aktien |
| Schonfeld Strategic Advisors LLC | $14.576.741 | 793.508 | 0,57% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $14.119.182 | 768.600 | 0,55% | Aktien |
| MORGAN STANLEY | $13.388.384 | 728.817 | 0,52% | Aktien |
| Woodline Partners LP | $12.876.066 | 700.929 | 0,50% | Aktien |
| JPMORGAN CHASE & CO | $12.106.209 | 639.929 | 0,47% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $12.079.892 | 657.588 | 0,47% | Aktien |
| PERCEPTIVE ADVISORS LLC | $10.690.973 | 581.980 | 0,42% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $9.939.235 | 541.058 | 0,39% | Aktien |
| EMERALD ADVISERS, LLC | $9.870.715 | 537.328 | 0,38% | Aktien |
| DEUTSCHE BANK AG\ | $8.870.414 | 482.875 | 0,35% | Aktien |
| ALGERT GLOBAL LLC | $8.858.694 | 482.237 | 0,34% | Aktien |
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II GP LLC ×9 Einreichungen | 13. Mai 2026 | 14,04% | Änderung | Passive Anlage | SEC |
| ATLAS VENTURE FUND VII, L.P., ATLAS VENTURE ASSOCIATES VII, L.P., ATLAS VENTURE ASSOCIATES VII, INC. ×2 Einreichungen | 14. Juni 2023 | · | Erste Einreichung | · | SEC |
| / Boulder Ventures V, L.P., / BV Partners V, L.L.C., / Boulder Ventures VI, L.P., / BV Partners VI, L.L.C., / Kyle Lefkoff, / Jonathan L. Perl, / Peter A. Roshko | 16. August 2017 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 7. März 2017 | · | Erste Einreichung | M&A / Verkauf | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 24. Februar 2017 | · | Erste Einreichung | M&A / Verkauf | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 40 Insider · 19 Führungskräfte · 24 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Stephen F. Mahoney | President and CEO | 3. März 2026 F | 33.349 | 0 | 0 | $0 |
| Scott Dunseth Myers | Chief Executive Officer | 12. April 2023 P | 259.500 | 0 | 0 | $0 |
| Jonathan Violin | Chief Executive Officer | 2. Februar 2023 M | 480.905 | 0 | 0 | $0 |
| William Stuart Marshall | President & CEO | 12. Februar 2020 A | 265.646 | 0 | 0 | $0 |
| Samuel D Riccitelli | President & CEO | 31. Oktober 2016 M | 571.370 | 0 | 0 | $0 |
| Seth Harmon | Chief Financial Officer | 3. März 2026 F | 7.850 | 0 | 0 | $0 |
| Kristian Humer | CFO and CBO | 8. Februar 2023 A | · | 0 | 0 | $0 |
| Jason A. Leverone | Chief Financial Officer | 18. Januar 2021 A | 48.829 | 0 | 0 | $0 |
| Tamara A Seymour | CFO, Secretary, Treasurer | 31. Oktober 2016 M | 106.447 | 0 | 0 | $0 |
| Thomas W. Beetham | Chief Operating Officer | 3. März 2026 F | 13.361 | 0 | 0 | $0 |
| Carrie Melvin | COO | 8. Februar 2023 A | · | 0 | 0 | $0 |
| Jennifer Tousignant | Chief Legal Officer | 19. August 2026 M | 0 | 0 | 3 | $-418.990 |
| Radhika Tripuraneni | Chief Medical Officer | 14. August 2026 M | 40.000 | 0 | 0 | $0 |
| Thomas Ciulla | Chief Medical Officer | 5. Februar 2024 A | · | 0 | 0 | $0 |
| Lara Meisner | Chief Legal Officer | 16. Juni 2023 M | 29.971 | 0 | 0 | $0 |
| Barrett Katz | Chief Medical Officer | 8. Februar 2023 A | 0 | 0 | 0 | $0 |
| Diana Escolar | Chief Medical Officer | 12. Februar 2020 A | · | 0 | 0 | $0 |
| Adam Scott Levy | Chief Business Officer | 6. Februar 2019 A | 10.540 | 0 | 0 | $0 |
| Paul D Rubin | EVP, Research & Development | 6. Februar 2019 A | · | 0 | 0 | $0 |
| Sarah Gheuens | Direktor | 1. Juli 2026 A | · | 0 | 0 | $0 |
| Tomas Kiselak | Direktor | 1. Juli 2026 A | · | 0 | 0 | $0 |
| Christopher W. Cain | Direktor | 1. Juli 2026 A | · | 0 | 0 | $0 |
| Jennifer K. Moses | Direktor | 1. Juli 2026 A | · | 0 | 0 | $0 |
| Jeffrey Robert Ajer | Direktor | 1. Juli 2026 A | · | 0 | 0 | $0 |
| Arlene Morris | Direktor | 1. Juli 2026 A | · | 0 | 0 | $0 |
| Peter Harwin | Direktor | 26. Juni 2024 A | · | 0 | 0 | $0 |
| Jeffrey S. Hatfield | Direktor | 4. Februar 2021 A | · | 0 | 0 | $0 |
| Joseph L Turner | Direktor | 4. Februar 2021 A | · | 0 | 0 | $0 |
| Thomas E. Hughes | Direktor | 21. Mai 2020 A | 12.827 | 0 | 0 | $0 |
| Christopher Bowden | Direktor | 21. Mai 2020 A | · | 0 | 0 | $0 |
| Kevin Koch | Direktor | 21. Mai 2020 A | · | 0 | 0 | $0 |
| Bruce Booth | Direktor | 27. Juni 2018 A | 1.351.090 | 0 | 0 | $0 |
| John W Creecy | Direktor | 28. Juni 2017 A | · | 0 | 0 | $0 |
| Kyle Lefkoff | Direktor | 28. Juni 2017 A | 463.473 | 0 | 0 | $0 |
| LEBOW BENNETT S | Direktor | 13. Februar 2017 M | 280.600 | 0 | 0 | $0 |
| David A Gonyer | Direktor | 8. Februar 2017 M | 1.899 | 0 | 0 | $0 |
| Robin L Smith | Direktor | 3. Februar 2017 M | 1.900 | 0 | 0 | $0 |
| Douglas A Schuling | Direktor | 15. Juni 2016 A | 10.500 | 0 | 0 | $0 |
| Logos Global Master Fund LP | 10%-Eigentümer | 13. November 2020 P | 550.000 | 0 | 0 | $0 |
| Lee M. Rauch | · | 18. Januar 2021 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 37 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,78% | 19.010 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,51% | 132.937 NS | 31. Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,48% | 306.726 SH | 11. September 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,14% | 1.816 NS | 31. Juli 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,14% | 93.739 NS | 31. Juli 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,09% | 70.285 SH | 19. August 2026 | Täglich |
| FFSM · FIDELITY COVINGTON TRUST | 0,08% | 62.894 NS | 31. Juli 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 25.498 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,07% | 2.305.679 SH | 11. September 2026 | Täglich |
| ESML · iShares Trust | 0,06% | 72.325 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,05% | 43.243 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 519.684 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 59.099 SH | 1. Oktober 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,04% | 331.726 NS | 31. Juli 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,03% | 8.493 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,02% | 10.323 SH | 11. September 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 36.733 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1.130.108 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 232.698 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,02% | 5.361 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,02% | 19.750 NS | 31. Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 89.350 SH | 11. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,01% | 3.037 NS | 31. Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 9.567 SH | 19. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,01% | 245.102 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 13.475 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 5.737 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 25.458 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 141.136 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 26.238 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 19.585 SH | 4. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.338.398 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7.732 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 757.567 SH | 11. September 2026 | Täglich |
| ISCB · iShares Trust | · | 4.277 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 13.384 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 5.861 SH | 4. September 2026 | Täglich |
VRDN Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 23 Analysten
KAUF
Median-Ziel
$36.50
+88,1%
8 34,8%
Starker Kauf
14 60,9%
Kauf
1 4,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
16 Analysten · 2026-09-29Mittelwert-Ziel $36.75 +89,4%
← Unter allen Zielen
Aktueller Preis $19.40
Tief$22.00
Mittelwert$36.75
Hoch$50.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | · |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | · |
| IRON | $3.01B | -13.2 | · | · | -31.3% | · |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | · |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | · |
| SLS | $577M | -15.1 | · | · | -55.4% | · |
| RXRX | $2.16B | -2.8 | 26.9% | -863.4% | -62.9% | · |
| VERA | · | -10.9 | · | · | -55.9% | · |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| MLYS | $2.96B | -15.8 | · | · | -32.2% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026